The Food and Drug Administration has fined the American Red Cross $16 million for violating blood safety laws. Although the FDA found no evidence that the errors had endangered patients or blood supplies, continued violations could harm future blood supplies, the agency said.
The fine stems from citations issued in 2008 and 2009, which flagged cases of inadequate donor screening, blood label mix-ups, potential air contamination and failures to investigate problems that the FDA had previously cited.
In a statement, the Red Cross said it was fully committed to making improvements, but said it was disappointed by the fine because 98 percent of the citations occurred before the organization had made significant improvements in its procedures.
The Red Cross collects and processes approximately 43 percent of America’s blood supply and is the largest supplier of blood, plasma and other blood products in the United States.
Since 2003, the FDA has cited the Red Cross 12 times and had imposed more than $21 million in fines before the latest penalty.


